ISSN: 2319-9865

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Quality of life in patients with metabolically healthy obesity before and after weight loss


Joint Event on Asia Pacific Conference on Diabetes & Oncology

December 04-05, 2019 | Tokyo, Japan

Tatiana Romantsova, Ostrovskaya E, Gerasimov A and Novoselova T

I.M. Sechenov First Moscow State Medical University, Russia

Posters & Accepted Abstracts: RRJMHS

Abstract

Obesity has a negative impact on the quality of life indicators; weight loss has a distinct positive effect on these parameters. The purpose of the study was to analyze Quality Of Life (QoL) indicators in patients with Metabolically Healthy Obesity (MHO) associated with ≥5% weight loss. The study involved 44 females with MHO (according to the IDF criteria of the Metabolic Syndrome (MS), 2005) and 33 females with Metabolically Unhealthy Obesity (MUHO) aged 19-59 years. To assess QoL, we used the SF-36 questionnaire (Medical Outcomes Study-Short Form 36). Initially QoL indicators in both groups were not significantly different statistically. The physical component of health (PHsum) in the MHO and MUHO groups averaged 53.9±6.7 and 50.6±6.3 points (p=0.032).The mental component of health (MHsum) averaged 42.1±1.8 and 45.1±1.8 points (p=0.255). The ≥5% decrease in body weight (from the initial body weight) after 6 months led to an increase in the indicators of physical role functioning by 11.6%, vitality by 12.8%, social functioning by 11.2%, emotional role functioning by 11.9%, mental health by 8.8% (p<0.05) in the MHO group, while in the MUHO group the indicators of physical role functioning increased by 24.6%, emotional role functioning by 39.5% and mental health by 9.2% (p<0.05). The MHO group is characterized by higher physical component of health, without a statistically significant difference in the indicators of each of the 8 scales of the SF-36 questionnaire. A≥5% decrease in the body mass in patients of both groups is accompanied by the increase in the indicators of QoL.

Biography

Tatiana Romantsova is currently working as a Professor at Department of Endocrinology in Sechenov University, Moscow. He is the author of 215 scientifi c articles.

E-mail: [email protected]

bestreplica